AI Stock Memo: CFBK - CF Bankshares - RankAlpha

CFBK

Rating neutralAI MemoPost-earnings T+3

CF Bankshares

As of 2026-05-16/Post-earnings T+3/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-05-16 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

neutral

Confidence

medium

Horizon

—

Key catalyst

Q1 earnings reset now hinges on whether late-quarter loan growth converts into cleaner Q2 revenue • 2026-05-16

Expected move: -2%

Biggest risk

The weaker interpretation is that the quarter did not fully clear the credit debate: Q1 NIM fell to 2.69% from 2.85% in Q4, the new $5.0 million non-core nonaccrual loan reduced interest income, past dues rose, and average-balance timing still hurt core earnings visibility. With low external coverage and no confirmed post-print revision set located, the thesis remains a monitoring view rather than a clean recovery call [#8-K-2026-05-05] [#10-Q-2026-05-11].

Invalidation

Break below $23 or thesis failure.

What would change my mind?

The best post-print argument is that Q1 still showed 13% year-over-year net income growth, positive core commercial loan growth, lower funding costs, rising fee income, strong capital ratios, and book value per share of $28.20, slightly above the May 15, 2026 anchor price of $27.21. If management is right that Q1 funding timing delayed revenue recognition into Q2, the stock could rerate modestly from a sub-book setup [#8-K-2026-05-05].

Research note

Recommendation

neutral

Confidence

medium

As of

2026-05-16

Base target

$28

p=45%

Bull target

$31

p=25%

Bear target

$23

p=30%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Credit normalization is still not fully proven after the added nonaccrual loan
Funding-cost relief and fee initiatives can support a gradual earnings recovery if execution holds
The best post-print argument is that Q1 still showed 13% year-over-year net income growth, positive core commercial loan growth, lower funding costs, rising fee income, strong capital ratios, and book value per share of $28.20, slightly above the May 15, 2026 anchor price of $27.21.

BearKey bullets

A $5.0 million non-core commercial loan moved to nonaccrual in Q1 and reduced reported interest income.
External coverage appears thin, so missing analyst revision data increases uncertainty rather than confirming a positive read-through.
Management's Q2 benefit case depends on late-quarter loan fundings sticking and payoffs easing, which is still unproven.

WatchKey bullets

Q1 earnings reset now hinges on whether late-quarter loan growth converts into cleaner Q2 revenue

Summary

High-level snapshot

Recommendation

neutral

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Post-earnings T+3

Base case: $28 (p=45%)

Bull/Bear spread: +8% / -20%

Vs latest close: Bull +8% · Base -2% · Bear -20%

Scenario probabilities

Bull Target: $31 (p=25%)Base Target: $28 (p=45%)Bear Target: $23 (p=30%)

Commentary

This was a cautious post-earnings follow-up. The queue referenced May 13, 2026, but the company’s actual Q1 earnings release and 8-K were filed on May 5, 2026. Market reaction was mildly negative at first: CFBK closed at $27.77 on May 4, $27.35 on May 5, and $26.75 on May 6, then recovered to $27.21 by May 15, suggesting the print did not trigger a decisive rerating. Trusted-news and analyst-revision evidence after the release was limited in this run, so sentiment remains monitoring-oriented rather than strongly bullish or capitulative.

As of 2026-05-16 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Credit normalization is still not fully proven after the added nonaccrual loan
Funding-cost relief and fee initiatives can support a gradual earnings recovery if execution holds

Scenarios

Bull Target (Scenario probability)

$31 / p=25% prob

Base Target (Scenario probability)

$28 / p=45% prob

Bear Target (Scenario probability)

$23 / p=30% prob

Price $29 as of 2026-05-27

Nearest Scenario: Base (∆ 2%)

Targets vs latest close: Bull +8% · Base -2% · Bear -20%

Sentiment & Exposure

News Sentiment (30d)

0.00

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-05-16
Q1 earnings reset now hinges on whether late-quarter loan growth converts into cleaner Q2 revenue
CF Bankshares reported Q1 2026 net income of $5.0 million, core commercial net loan growth of $45 million, and management said heavier fundings arrived late in the quarter, with expected interest-income benefit beginning in Q2. The same release also disclosed a $5.0 million non-core loan moved to nonaccrual, cutting Q1 interest income by $528,000 and reducing NIM by 11 bps, so the next read-through is whether growth carries into revenue without another credit drag [#8-K-2026-05-05] [#10-Q-2026-05-11].
Prob 65.00% • Move 7.00% • Priced-in 55.00%

Short-term Catalysts

Next few weeks

Credit normalization is still not fully proven after the added nonaccrual loan
2026-08-15
Asset-quality metrics weakened in Q1 as nonaccrual loans rose to $20.3 million from $15.3 million at year-end, loans 30 days or more past due rose to $17.5 million from $12.9 million, and the allowance ratio increased to 1.05% from 1.01%. Management framed the new problem loan as a non-core non-customer exposure, but another reserve or nonaccrual surprise would likely pressure a low-coverage micro-cap bank multiple [#8-K-2026-05-05] [#10-Q-2026-05-11].
Prob 40% • Move -14% • Priced-in 35%

Long-term Catalysts

Months to a year

Funding-cost relief and fee initiatives can support a gradual earnings recovery if execution holds
2026-12-31
Management highlighted a 34 bps year-over-year and 15 bps sequential decline in cost of funds, a 23% increase in noninterest income, and continued treasury-management and swap-fee initiatives. If those trends persist while commercial banking teams add full C&I relationships, CFBK has a plausible but still unproven path to better profitability and scale [#8-K-2026-05-05].
Prob 55% • Move 9% • Priced-in 50%

Risks

A $5.0 million non-core commercial loan moved to nonaccrual in Q1 and reduced reported interest income.
External coverage appears thin, so missing analyst revision data increases uncertainty rather than confirming a positive read-through.
Management's Q2 benefit case depends on late-quarter loan fundings sticking and payoffs easing, which is still unproven.
Net interest margin fell sequentially to 2.69% from 2.85% in Q4 2025 despite year-over-year improvement.
Nonaccrual loans rose to $20.3 million and loans 30 days or more past due rose to $17.5 million as of March 31, 2026.

Peers

Symbol	Summary
CBFV	CB Financial Services is a closer size-and-sector peer; for both banks, the debate is less about headline growth and more about whether credit costs and deposit economics stay controlled enough to protect valuation.
EBMT	Eagle Bancorp Montana is another small-bank comp where investors typically focus on funding mix, local-loan growth, and asset quality; CFBK currently looks similar in that execution matters more than broad sector beta.
FINW	FinWise Bancorp is not a perfect business-match peer, but it is a similarly sized bank where investors watch earnings durability and niche-loan risk closely; versus FINW, CFBK's current swing factor is community-bank credit and margin follow-through.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Human targets: serper
Analysis date: 2026-05-16